More on Arthrocare Q1 results


Total revenues: $96.1M (+4.1%): product sales: $90M (+2.9%),  royalties/other: $6.1M (+24.5%).

Product sales: Sports Medicine: $63.8M (+7.0%), ENT: $24.3M (-5.1%), Other: $1.8M (-18.2%).

Operating income: $9.2M (-31.9%).

Net Income: $6.2M (-44.6%), EPS: $0.10 (-66.7%).

Cash and equivalents at quarter end: $191M.

CF Ops: -$20.6M compared to +$19.5M yoy.

(ARTC)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs